Cata Juan P, Lasala Javier, Pratt Greg, Feng Lei, Shah Jay B
Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Anesthesiology and Surgical Oncology Research Group, Houston, TX 77030, USA.
Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
J Blood Transfus. 2016;2016:9876394. doi: 10.1155/2016/9876394. Epub 2016 Jan 31.
Background. Perioperative blood transfusions are associated with poor survival in patients with solid tumors including bladder cancer. Objective. To investigate the impact of perioperative blood transfusions on oncological outcomes after radical cystectomy. Design. Systematic review and meta-analysis. Setting and Participants. Adult patients who underwent radical cystectomy for bladder cancer. Intervention. Packed red blood cells transfusion during or after radical cystectomy for bladder cancer. Outcome Measurements and Statistical Analysis. Recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). We calculated the pooled hazard ratio (HR) estimates and 95% confidence intervals by random and fixed effects models. Results and Limitation. Eight, seven, and five studies were included in the OS, CSS, and RFS analysis, respectively. Blood transfusions were associated with 27%, 29%, and 12% reduction in OS, CSS, and RFS, respectively. A sensitivity analysis supported the association. This study has several limitations; however the main problem is that it included only retrospective studies. Conclusions. Perioperative BT may be associated with reduced RFS, CSS, and OS in patients undergoing RC for BC. A randomized controlled study is needed to determine the causality between the administration of blood transfusions and bladder cancer recurrence.
背景。围手术期输血与包括膀胱癌在内的实体瘤患者的不良生存结局相关。目的。探讨围手术期输血对根治性膀胱切除术后肿瘤学结局的影响。设计。系统评价和荟萃分析。研究地点和参与者。接受膀胱癌根治性膀胱切除术的成年患者。干预措施。在膀胱癌根治性膀胱切除术期间或之后输注浓缩红细胞。结局测量和统计分析。无复发生存期(RFS)、癌症特异性生存期(CSS)和总生存期(OS)。我们通过随机效应模型和固定效应模型计算合并风险比(HR)估计值和95%置信区间。结果与局限性。OS、CSS和RFS分析分别纳入了8项、7项和5项研究。输血分别使OS、CSS和RFS降低了27%、29%和12%。敏感性分析支持这种关联。本研究有几个局限性;然而,主要问题是它仅纳入了回顾性研究。结论。围手术期输血可能与接受膀胱癌根治性膀胱切除术患者的RFS、CSS和OS降低有关。需要进行一项随机对照研究来确定输血与膀胱癌复发之间的因果关系。